69.60
Henry Schein Inc stock is traded at $69.60, with a volume of 1.43M.
It is up +2.04% in the last 24 hours and down -3.60% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$68.21
Open:
$68.75
24h Volume:
1.43M
Relative Volume:
0.82
Market Cap:
$8.44B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
28.52
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+2.59%
1M Performance:
-3.60%
6M Performance:
-9.89%
1Y Performance:
-0.34%
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
HSIC
Henry Schein Inc
|
69.60 | 8.15B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
MCK
Mckesson Corporation
|
689.45 | 83.49B | 377.60B | 3.35B | 5.67B | 25.08 |
![]()
COR
Cencora Inc
|
292.60 | 56.29B | 316.65B | 1.91B | 1.14B | 9.72 |
![]()
CAH
Cardinal Health Inc
|
148.10 | 35.75B | 222.58B | 1.57B | 1.85B | 6.45 |
![]()
AHG
Akso Health Group Adr
|
1.77 | 701.93M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-25-25 | Downgrade | Stifel | Buy → Hold |
Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
Dec-04-24 | Initiated | Mizuho | Neutral |
Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
Nov-10-23 | Upgrade | Stifel | Hold → Buy |
Aug-08-22 | Upgrade | UBS | Sell → Neutral |
Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
May-13-22 | Resumed | Credit Suisse | Outperform |
Jan-31-22 | Initiated | Morgan Stanley | Underweight |
Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Oct-01-21 | Resumed | Credit Suisse | Neutral |
Feb-08-21 | Resumed | Piper Sandler | Overweight |
Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
May-30-19 | Initiated | Wolfe Research | Underperform |
May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-18-19 | Initiated | Guggenheim | Buy |
Jan-17-19 | Initiated | UBS | Sell |
Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
Nov-08-18 | Reiterated | Barrington Research | Outperform |
Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
Oct-19-18 | Resumed | Goldman | Neutral |
Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
Aug-07-18 | Reiterated | Stifel | Hold |
Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein : Corporate Citizenship (2024CARESReport) - MarketScreener
Henry Schein : Corporate Citizenship (2024ISSBReportIndex) - MarketScreener
Stock Analysis | Henry Schein OutlookA Wait-and-See Moment Amid Mixed Signals - AInvest
Henry Schein Releases 2024 CARES Report on Sustainability and Corporate Citizenship - Orthodontic Products
Henry Schein Hosts Annual Back to School Event - Dentistry Today
Henry Schein goes ‘Back to School’ - HME News
Henry Schein’s 28th Annual ‘Back to School’ Program Supports Students Worldwide - Eagle-Tribune
Sentiment Tools Show Shift in Trader Mood on Henry Schein Inc.2025 Valuation Update & Fast Entry Momentum Alerts - beatles.ru
Henry Schein Inc. Recovery Linked to Earnings Surprise2025 Trading Recap & Weekly Momentum Stock Picks - beatles.ru
Henry Schein Inc. Hits Oversold Level on RSI Indicator2025 Risk Factors & Target Return Focused Stock Picks - metal.it
Can Henry Schein Inc. expand into new marketsMarket Sentiment Report & Community Trade Idea Sharing - thegnnews.com
Henry Schein Reports Second Quarter 2025 Financial Results - ADVFN Brasil
Will Henry Schein Inc. Benefit From Sector Tailwinds2025 Market WrapUp & High Conviction Buy Zone Alerts - beatles.ru
What’s the beta of Henry Schein Inc. stockJuly 2025 Breakouts & Accurate Trade Setup Notifications - newsyoung.net
Upgrade Henry Schein to Buy: Growth, Strong Tailwinds, and Solid Balance Sheet - AInvest
Henry Schein: The Case For An Upgrade From Hold To Buy (NASDAQ:HSIC) - Seeking Alpha
Published on: 2025-08-14 07:59:18 - beatles.ru
Henry Schein Powers Growth at Annual Dykema Event - Dentistry Today
Henry Schein says new saliva testing partnership will ‘advance prevention’ - Oral Health Group
How Henry Schein’s (HSIC) Massive Share Buyback Completion Could Shift Its Capital Return Narrative - simplywall.st
The Top 5 Analyst Questions From Henry Schein’s Q2 Earnings Call - Yahoo Finance
Oral Genome Partners with Henry Schein to Expand Saliva Testing Access - Orthodontic Products
Oral Genome Partners with Henry Schein Nationwide - Dentistry Today
Henry Schein shares rise 1.04% after-hours after showcasing innovative solutions and sponsoring volunteer event. - AInvest
Henry Schein Director Buys 10,000 Shares at $67.08 Per Share - AInvest
Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials? - 富途牛牛
Henry Schein (HSIC) Q2 EPS Drops 11% - AOL.com
Henry Schein, Inc. Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Miss: Henry Schein, Inc. Missed EPS By 24% And Analysts Are Revising Their Forecasts - Yahoo Finance
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top - MSN
Henry Schein maintains 2025 EPS guidance and targets over $100M in annual cost savings as CEO transition begins - MSN
Henry Schein Unveils New Cordless Hygiene Handpiece - Dentistry Today
Henry Schein (HSIC): Barrington Research Lowers Price Target | H - GuruFocus
Research Alert: CFRA Maintains Hold View On Shares Of Henry Schein, Inc. - 富途牛牛
Henry Schein 2025 Q2 Earnings Misses Targets, EPS Declines 12.3% - AInvest
Henry Schein Introduces ACCLEAN Cordless Hygiene Handpiece - Orthodontic Products
Henry Schein, Inc. (NASDAQ:HSIC) Q2 2025 Earnings Call Transcript - Insider Monkey
Henry Schein Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Evercore ISI Adjusts Price Target on Henry Schein to $70 From $78, Maintains In Line Rating - MarketScreener
Mizuho Adjusts Price Target on Henry Schein to $74 From $76, Maintains Neutral Rating - MarketScreener
Henry Schein Inc (HSIC) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Market Challenges By GuruFocus - Investing.com Canada
Decoding Henry Schein Inc (HSIC): A Strategic SWOT Insight - GuruFocus
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein: Q2 Earnings Snapshot - Chron
Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution - AOL.com
Henry Schein falls after missing quarterly profit estimates - whbl.com
Henry Schein Q2 Earnings Miss Estimates, Revenue Grows 3.3% - AInvest
Henry Schein Q2 2025 slides: sales growth continues despite margin pressure - Investing.com
Why Henry Schein (HSIC) Shares Are Falling Today - Yahoo Finance
Henry Schein (HSIC) Q2 EPS Drops 11% - The Motley Fool
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Henry Schein Inc Stock (HSIC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):